| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | 31-Dec-06 | | Total Revenue | 1,500 | 1,003 |
-
| | Cost of Revenue |
-
|
-
|
-
| | | Gross Profit | 1,500 | 1,003 |
-
| | | Operating Expenses | | Research Development | 10,066 | 3,975 | 319 | | Selling General and Administrative | 5,670 | 4,954 | 3,056 | | Non Recurring |
-
|
-
|
-
| | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | (14,236) | (7,926) | (3,375) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 1,024 | 1,423 | 275 | | Earnings Before Interest And Taxes | (13,212) | (6,503) | (3,100) | | Interest Expense | 3 | 0 | 1,081 | | Income Before Tax | (13,215) | (6,503) | (4,181) | | Income Tax Expense |
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (13,215) | (6,503) | (4,181) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (13,215) | (6,503) | (4,181) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($13,215) | ($6,503) | ($4,181) |
|
0.29% Nasdaq 
0.13 (2.72%) 
Income Statement
